A year of treatment with carbidopa and levodopa in Parkinsonian patients
Martínez-Lage, J.M.; Marti-Massó, J.F.; Delgado, G.; Carreray, N.; Del Amo, F.
Revista Clinica Espanola 134(6): 535-542
1974
ISSN/ISBN: 0014-2565 PMID: 4450036 Document Number: 82706
Document emailed within 1 workday
Related Documents
Lieberman, A.N.; Gopinathan, G.; Neophytides, A.; Pasternack, P. 1986: Use of carbidopa as an adjuvant to levodopa/carbidopa therapy in patients with Parkinson's disease New York State Journal of Medicine 86(12): 655-656Arai, M. 2012: Levodopa in combination with carbidopa does not affect plasma arginine vasopressin levels in treatment-naïve older patients with Parkinson's disease: a before-after study Neuro Endocrinology Letters 33(1): 34-36
Timofeeva, A.A. 2014: Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(11): 145-151
Fernandez-Pajarin, G.; Ares-Pensado, B.; Sesar, A.; Iglesias-Canle, J.; Masa-Vazquez, L.; Castro, A. 2018: Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease Revista de Neurologia 67(1): 1-5
Hauser, R.A. 2004: Levodopa/carbidopa/entacapone (Stalevo) Neurology 62(1 Suppl 1): S64-S71
Melamed, E. 1995: Does treatment with dopamine agonists affect utilization of exogenous levodopa in the parkinsonian striatum? Journal of Neural Transmission. Supplementum 45: 57-60
Klivényi, P.ét.; Vécsei, L.ás.ó 2014: Clinical studies with levodopa/carbidopa intestinal gel Ideggyogyaszati Szemle 67(1-2): 5-8
Rudakova, A.V.; Yakupov, E.Z. 2014: Pharmacoeconomic aspects of using levodopa/carbidopa intestinal gel in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10): 117-121
Rabadeau Dumas, J.L.; Rondot, P.; Cardon, P. 1977: Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor Therapie 32(2): 161-172
Shoulson, I. 1983: Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia Advances in Neurology 37: 259-266
Battista, A.F.; Wolff, B.B. 1973: Levodopa and induced-pain response. a study of patients with Parkinsonian and pain syndromes Archives of Internal Medicine 132(1): 70-74
Cabo-López, I.; García-Bermejo, P.; García-Ruiz, P.J. 2007: Levodopa withdrawal symptoms in a non-Parkinsonian patient Revista de Neurologia 45(3): 190
Sigwald, J.; Chomette, G.; Raymondeaud, C. 1972: Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients La semaine des hopitaux: organe fonde par l'Association d'enseignement medical des hopitaux de Paris 48(9): 609-624
Mark, M.H.; Sage, J.I. 1989: Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease Annals of Clinical and Laboratory Science 19(2): 101-106
Stern, P.H.; McDowell, F.; Miller, J.M.; Robinson, M. 1970: Levodopa and physical therapy in treatment of patients with Parkinson's disease Archives of Physical Medicine and Rehabilitation 51(5): 273-277
Bergonzi, P.; Chiurulla, C.; Tempesta, E. 1971: Organization of nocturnal sleep in parkinsonian patients: modifications of the phases and cycles in the course of pharmacological treatment Rivista di Neurologia 41(5): 326-334
Sage, J.I.; Trooskin, S.; Sonsalla, P.K.; Heikkila, R.E. 1989: Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease Neurology 39(11 Suppl 2: 60
McMeekin, H. 2007: Treatment of bipolar disorder, restless legs syndrome and parkinsonian symptoms using lamotrigine: a report of seven patients Journal of the South Carolina Medical Association 103(3): 69-73
Benedetto, G. di; Gallamini, A.; Nizzo, M.C.; Costa, M.; Indiveri, F. 1976: Effects of the treatment with an antiestrogen(tamoxifen) and levodopa on the secretion of prolactin in patients affected by breast cancer Bollettino della Societa Italiana di Biologia Sperimentale 52(19): 1572-1575
Shan, D.E.; Yeh, S.I. 1996: An add-on study of selegiline to Madopar in the treatment of parkinsonian patients with dose-related fluctuations: comparison between Jumexal and Parkryl Zhonghua Yi Xue Za Zhi 58(4): 264-268